In Vivo and in Vitro Activity And Mechanism Of Action of the Multidrug Cytarabine-L-Glycerylyl-Fluorodeoxyuridine

REFERENCES

• Peters , G. J. and Ackland , S. P. 1996 . New antimetabolites in preclinical and clinical development . Expert Opinion Invest. Drugs , 5 : 637 – 679 .
   Google Scholar
• Peters , G. J. and Jansen , G. 1996 . “ Resistance to antimetabolites ” . In Principles of Antineoplastic Drug Development and Pharmacology , Edited by: Schilsky , R. L. , Milano , G. A. and Ratain , M. J. 543 – 585 . New York : Marcel Dekker, Inc. .
   Google Scholar
• Kuchta , R. D. , Ilsley , D. , Kravig , K. D. , Schubert , S. and Harris , B. 1992 . Inhibition of DNA primase and polymerase alpha by arabinofuranosylnucleoside triphosphates and related compounds . Biochemistry , 31 : 4720 – 4728 .
   PubMed Web of Science ®Google Scholar
• Johnston , P. H. , Drake , J. C. , Trepel , J. and Allegra , C. J. 1992 . Immunological quantitation of thymidylate synthase using the monocolonal antibody TS 106 in 5-fluorouracil-sensitivie and -resistant human cancer cell lines . Cancer Res. , 52 : 4306 – 4312 .
   PubMed Web of Science ®Google Scholar
• Peters , G. J. , van der Wilt , C. L. , van Groeningen , C. J. , Meijer , S. , Smid , K. and Pinedo , M. 1994 . Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil . J. Clin. Oncol. , 12 : 2035 – 2042 .
   PubMed Web of Science ®Google Scholar
• Keepers , Y. P. , Pizao , P. E. , Peters , G. J. , Van Ark-Otte , J. , Winograd , B. and Pinedo , H. M. 1991 . Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing . Eur. J. Cancer , 27 : 897 – 900 .
   PubMed Web of Science ®Google Scholar
• van Haperen , R. , Veerman , G. , Eriksson , S. , Boven , E. , Stegmann , A. P.A. , Hermsen , M. , Vermorken , J. B. , Pinedo , H. M. and Peters , G. J. 1994 . Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780 . Cancer Res. , 54 : 4138 – 4143 .
   PubMed Web of Science ®Google Scholar
• Balzarini , J. , de Clercq , E. , Ayusawa , D. and Seno , T. 1985 . Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds . FEBS Lett. , 185 : 95 – 100 .
   PubMed Web of Science ®Google Scholar
• Noordhuis , P. , Kazemier , K. M. , Kaspers , G. J. and Peters , G. J. 1996 . Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines . Leuk. Res. , 20 : 127 – 134 .
   PubMed Web of Science ®Google Scholar
• Van , d er , Wilt , C. L. , Smid , K. , Noordhuis , P. , Aherne , G. W. and Peters , G. J. 1997 . Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells . Eur. J. Cancer , 33 : 471 – 478 .
   PubMed Web of Science ®Google Scholar
• Kroep , J. R. , Giaccone , G. , Voorn , D. A. , Smit , E. , Beijnen , J. H. , Rosing , H. , Van Moorsel , C. J.A. , Van Groeningen , C. J. , Postmus , P. E. , Pinedo , H. M. and Peters , G. J. 1999 . Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer . J. Clin. Oncol. , 17 : 2190 – 2197 .
   PubMed Web of Science ®Google Scholar
• Fichtner , I. , Slisow , W. , Gill , J. , Becker , M. , Elbe , B. , Hillebrand , T. and Bibby , M. 2004 . Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas . European J. Cancer , 40 : 298 – 307 .
   PubMed Web of Science ®Google Scholar
• Saiko , P. , Horvath , Z. , Illmer , C. , Madlener , S. , Bauer , W. , Hoechtl , T. , Erlach , N. , Grusch , M. , Krupitza , G. , Mader , R. , Jaeger , W. , Schott , H. , Agarwal , R. R. , Fritzer-Szekeres , M. and Szekeres , T. 2005 . Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells . Leuk. Res. , 29 : 785 – 791 .
   PubMed Web of Science ®Google Scholar
• Belt , J. A. , Marina , N. M. , Phelps , D. A. and Crawford , C. R. 1993 . Nucleoside transport in normal and neoplastic cells . Adv. Enzyme Regul. , 33 : 235 – 252 .
   PubMedGoogle Scholar
• Peters , G. J. , Laurensse , E. , Leyva , A. , Lankelma , J. and Pinedo , H. M. 1986 . Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes . Cancer Res. , 46 : 20 – 28 .
   PubMed Web of Science ®Google Scholar
• Horber , D. H. , Cattaneo-Pangrazzi , R. M. , von Ballmoos , P. , Schott , H. , Ludwig , P. S. , Eriksson , S. , Fichtner , I. and Schwendener , R. 2000 . Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5′– > 5′)-N4-octadecyl-1-beta-D-arabinofuranosylcytosi ne . J. Cancer Res. Clin. Oncol. , 126 : 311 – 319 .
   PubMed Web of Science ®Google Scholar